Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of Effectiveness of Interferon and Ribavirin Treatment in Thalassemia Major Patients With Chronic Viral Hepatitis C

NCT00887081 is registered in ClinicalTrials.gov with Azienda Ospedaliera V. Cervello as lead sponsor.

NCT NCT00887081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00887081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of Effectiveness of Interferon and Ribavirin Treatment in Thalassemia Major Patients With Chronic Viral Hepatitis C
Lead sponsor
Azienda Ospedaliera V. Cervello
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2009
Completion date
December 31, 2013
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemoglobinopathies